Drugs targeting protease-activated receptor-4 improve the anti-thrombotic therapeutic window.

ABSTRACT:

SUBMITTER: French SL 

PROVIDER: S-EPMC5733327 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature